FLT3 and acute myeloid leukemia: In addition, in a multivariate survival analysis including OX40 expression (high vs low expression), patients’ age (< 60 vs. ≥ 60 years), FLT3-ITD mutational status and ASCT status, OX40 expression on AML blasts was identified as independent risk factor for dismal outcome (Fig. 3f).